
|Videos|August 3, 2020
Pharmaceutical CEO Leadership During the Pandemic
From COVID day-to-day management, to the future of the workforce In this segment, members of the, Pharmaceutical CEO Leadership During the Pandemic panel discuss the first order of business when restrictions began to how they envision employee safety and operations in the future.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5





